NCT01308320

Brief Summary

Fentanyl is expected to suppress tracheal tube-induced cough during emergence from general anaesthesia through binding to its receptors in the brainstem. However, it has not been proven if fentanyl has a complication-free, dose-dependent effect on cough suppression during emergence from sevoflurane anaesthesia. The purpose of this study is to evaluate the relationship between fentanyl doses and cough suppression during emergence from sevoflurane anaesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Feb 2010

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 3, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 4, 2011

Completed
Last Updated

March 4, 2011

Status Verified

March 1, 2011

Enrollment Period

5 months

First QC Date

March 3, 2011

Last Update Submit

March 3, 2011

Conditions

Study Arms (4)

saline

PLACEBO COMPARATOR

control group

Drug: saline

F1 group

ACTIVE COMPARATOR

F1 group : fentanyl 1 mcg/kg

Drug: fentanyl citrate

F1.5 group

ACTIVE COMPARATOR

F1.5 group : fentanyl 1.5 mcg/kg

Drug: fentanyl citrate

F2 group

ACTIVE COMPARATOR

F2 group : fentanyl 2 mcg/kg

Drug: fentanyl citrate

Interventions

According to the enrolled group, certain dose of fentanyl is intravenously administered by bolus just after sevoflurane discontinuation.

F1 groupF1.5 groupF2 group
salineDRUG

According to the enrolled group, certain dose of saline is intravenously administered by bolus just after sevoflurane discontinuation.

saline

Eligibility Criteria

Age20 Years - 59 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • the patients undergoing general anaesthesia for elective thyroidectomy due to thyroid neoplasm.
  • ASA I-II.
  • years old.
  • female only.

You may not qualify if:

  • signs of difficult intubation.
  • risks for perioperative pulmonary aspiration.
  • history of chronic respiratory disease.
  • recent upper respiratory track infection.
  • previous and recent smoking history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Severance Hospital

Seoul, 120-752, South Korea

Location

Related Publications (2)

  • Tagaito Y, Isono S, Nishino T. Upper airway reflexes during a combination of propofol and fentanyl anesthesia. Anesthesiology. 1998 Jun;88(6):1459-66. doi: 10.1097/00000542-199806000-00007.

    PMID: 9637637BACKGROUND
  • Nishina K, Mikawa K, Maekawa N, Obara H. Fentanyl attenuates cardiovascular responses to tracheal extubation. Acta Anaesthesiol Scand. 1995 Jan;39(1):85-9. doi: 10.1111/j.1399-6576.1995.tb05597.x.

    PMID: 7725888BACKGROUND

MeSH Terms

Conditions

Thyroid Neoplasms

Interventions

FentanylSodium Chloride

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 3, 2011

First Posted

March 4, 2011

Study Start

February 1, 2010

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

March 4, 2011

Record last verified: 2011-03

Locations